Evidence map›Paper›PMID 24599953›Full record

ArticleThe Journal of biological chemistry2014

Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and PH domain and leucine-rich repeat phosphatase cross-talk (PHLPP) in cancer cells and in transforming growth factor β-activated stem cells.

Aram Ghalali, Zhi-Wei Ye, Johan Högberg, Ulla Stenius

RetractedAbstract readRetracted Publication
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Aram GhalaliInstitute of Environmental Medicine, Karolinska Institutet, S-171 77 Stockholm, Sweden. Electronic address: aram.ghalali@ki.se.
Zhi-Wei YeInstitute of Environmental Medicine, Karolinska Institutet, S-171 77 Stockholm, Sweden.
Johan HögbergInstitute of Environmental Medicine, Karolinska Institutet, S-171 77 Stockholm, Sweden.
Ulla SteniusInstitute of Environmental Medicine, Karolinska Institutet, S-171 77 Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Akt kinase controls cell survival, proliferation, and invasive growth and is a critical factor for cancer development. Here we describe a cross-talk between phosphatases that may preserve levels of activated/phosphorylated Akt and confer aggressive growth of cancer cells. In prostatic cancer cells, but not in non-transformed cells or in prostate stem cells, we found that the phosphatase and tensin homolog deleted on chromosome 10 (PTEN) overexpression down-regulated PH domain and leucine-rich repeat phosphatase (PHLPP) and that PHLPP overexpression down-regulated PTEN. We also show that silencing PTEN by siRNA increased the levels of PHLPPs. This cross-talk facilitated invasive migration and was mediated by epigenetic alterations, including activation of miR-190, miR-214, polycomb group of proteins, as well as DNA methylation. A role for the purinergic receptor P2X4, previously associated with wound healing, was indicated. We also show that TGF-β1 induced cross-talk concomitant with epithelial-mesenchymal transition in stem cells. The cross-talk emerged as an integrated part of epithelial-mesenchymal transition. We conclude that cross-talk between PTEN and PHLPPs is silenced in normal prostate cells but activated in TGF-β1 transformed prostate stem and cancer cells and facilitates invasive growth.

Indexed as

AnimalsBase SequenceCell Line, TumorDNA PrimersEpigenesis, GeneticHumansMaleNuclear ProteinsPhosphoprotein PhosphatasesProstatic NeoplasmsPTEN PhosphohydrolaseRatsRats, Inbred F344Real-Time Polymerase Chain ReactionStem CellsTranscription, GeneticDNA PrimersNuclear ProteinsPHLPP1 protein, humanPhosphoprotein PhosphatasesPTEN PhosphohydrolasePTEN protein, humanTransforming Growth Factor betaAktPHLPP1PHLPP2Prostate CancerProtein PhosphatasePTENStem Cells

Identifiers

PMID24599953
PMCPMC4002071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.